ECSP077219A - Tratamiento de cáncer - Google Patents

Tratamiento de cáncer

Info

Publication number
ECSP077219A
ECSP077219A ECSP077219A ECSP077219A EC SP077219 A ECSP077219 A EC SP077219A EC SP077219 A ECSP077219 A EC SP077219A EC SP077219 A ECSP077219 A EC SP077219A
Authority
EC
Ecuador
Prior art keywords
cancer treatment
cancer
treatment
leukemia
preparations
Prior art date
Application number
Other languages
English (en)
Inventor
James Peter Burnie
Ruth Christine Matthews
Tracey Carter
Original Assignee
Neutec Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0414885A external-priority patent/GB0414885D0/en
Priority claimed from GB0420845A external-priority patent/GB0420845D0/en
Priority claimed from GB0503566A external-priority patent/GB0503566D0/en
Application filed by Neutec Pharma Plc filed Critical Neutec Pharma Plc
Publication of ECSP077219A publication Critical patent/ECSP077219A/es

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a medicamentos y preparados novedosos que comprende agentes anti-cáncer efectivos junto con un anticuerpo anti-Hsp90 los cuales juntos proveen una eficacia incrementada en el tratamiento de cáncer, y leucemia.
ECSP077219 2004-07-02 2007-02-02 Tratamiento de cáncer ECSP077219A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0414885A GB0414885D0 (en) 2004-07-02 2004-07-02 Cancer therapy
GB0420845A GB0420845D0 (en) 2004-09-20 2004-09-20 Treatment of cancer
US61442304P 2004-09-30 2004-09-30
GB0503566A GB0503566D0 (en) 2005-02-21 2005-02-21 Treatment for cancer
US65445805P 2005-02-22 2005-02-22

Publications (1)

Publication Number Publication Date
ECSP077219A true ECSP077219A (es) 2007-03-29

Family

ID=39124615

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP077219 ECSP077219A (es) 2004-07-02 2007-02-02 Tratamiento de cáncer

Country Status (8)

Country Link
JP (1) JP2008504355A (es)
BR (1) BRPI0512889A (es)
EC (1) ECSP077219A (es)
IL (1) IL180460A (es)
MA (1) MA28701B1 (es)
MX (1) MX2007000263A (es)
NZ (1) NZ552508A (es)
SG (1) SG153877A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008305D0 (en) * 2000-04-06 2000-05-24 Neutec Pharma Plc Treatment of fungal infections

Also Published As

Publication number Publication date
MX2007000263A (es) 2007-07-20
IL180460A0 (en) 2007-06-03
BRPI0512889A (pt) 2008-04-15
NZ552508A (en) 2009-10-30
SG153877A1 (en) 2009-07-29
MA28701B1 (fr) 2007-06-01
JP2008504355A (ja) 2008-02-14
IL180460A (en) 2010-12-30

Similar Documents

Publication Publication Date Title
CY1125064T1 (el) Συζευγματα φαρμακων συνδετων βητα-γλυκουρονιδιου
NL300936I2 (nl) Semaglutide
ATE461217T1 (de) Glp-1-verbindungen
HN2002000030A (es) Nueva sal succinato de o-desmetil-venlafaxina
AR027355A1 (es) Acidos tiazolidincarboxilicos
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
UY27720A1 (es) Aroilpiridinonas monocíclicas,
NO20070580L (no) Behandling av cancer.
CY1111622T1 (el) Ανθρωποποιημενοι ανταγωνιστες anti-cmet
DE602005026789D1 (de) Le
CY1112277T1 (el) ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ΑΝΤΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
NL1026071A1 (nl) Collimatorsamenstel met uit meerdere delen bestaande componenten.
CY1114904T1 (el) Prlr-ειδικο αντισωμα και χρησεις αυτου
ECSP045286A (es) Indazoles sustituidos con una actividad anticancerosa
DK1853250T3 (da) Kombinationer og måder til indgivelse af terapeutiske midler og kombinationsterapi
TR200504892A1 (tr) Belirti göstermeyen tüberküloz tedavisi
CY1115212T1 (el) Διαμεσολαβηση στην κυτταροτοξικοτητα των κυτταρων που παρουσιαζουν eπιφaneiakh εκφραση της cd44
EA201070463A1 (ru) Комбинированная терапия с использованием конъюгатов антитело-лекарственное средство
CR8767A (es) Indazoles sustituidos, composiciones que los contienen, procedimiento de preparacion y su uso
AR053338A1 (es) Terapia antiproliferativa combinada usando ciertos agentes quimioterapeuticos basados en platino y taxanos
ECSP21089206A (es) Conjugados de anticuerpo y fármaco
PA8604401A1 (es) Productos aril-heteroaromaticos, composiciones que los contienen y su utilizacion.
UY29236A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización.
SE0301650D0 (sv) Novel compounds